Earnings call transcript: IWG Q3 2026 lifts outlook as stock jumps 6.7%

IWG reported Q3 2026 systemwide revenue of $1.26 billion, up 12% year over year, and group revenue of $1.03 billion, up 9%; managed and franchised systemwide revenue rose 27%. Management expects full-year adjusted EBITDA to exceed the $599 million consensus, within its $585 million-$625 million range, and increased the 2026 buyback program to up to $200 million; $139 million had been repurchased in the first nine months. Shares rose 6.74% to $210.6 after the update.

Analysis

The key valuation question is whether capital-light growth becomes cash earnings quickly enough to justify paying for a future fee stream today. Managed/franchised room growth expands the platform, but systemwide revenue is not IWG’s recognized revenue: recurring management fees remain a relatively small earnings base, and new sites reportedly take about 30 months to mature. That creates a lag between openings and dependable fee contribution; any slowdown in partner openings or weaker cohort ramp could leave the market capitalizing the flywheel too early.

Near term, the rally has likely pulled forward much of the guidance signal. The stated consensus comparison also needs reconciliation: management says EBITDA should exceed $599 million consensus, while the cited range begins below that level. The “six” comment implies confidence, but investors should verify the actual year-end run rate rather than treat the range itself as an upgrade. Cash conversion is a second-order risk: net debt improvement alongside buybacks is encouraging, but reduced supply-chain financing and working-capital timing complicate the underlying free-cash-flow read-through.

Over 1–3 months, the catalysts are FY results and initial 2027 guidance, with recurring fee progression and cash generation more informative than headline systemwide growth. Over 6–18 months, successful cohort maturation and cost leverage could support a higher-quality multiple; conversely, stable company-owned RevPAR growth and a long ramp leave earnings exposed if demand weakens. Contrarian view: the market may be underpricing the eventual fee mix, but is at risk of overpricing near-term conversion. No chase after the sharp reaction; the thesis is falsified by slowing room openings, deteriorating mature-center RevPAR, or weak cash generation as fees scale.

Key Decisions for Investors

• Do not add to IWG immediately after the repricing. Reassess after FY results and 2027 guidance; require evidence that recurring fees are tracking toward the stated 2026 target and that operating cash generation remains positive after buybacks.
• Treat IWG as a watch-list long on a material pullback, conditional on stable mature-center RevPAR and continued partner openings. The upside case is fee growth plus operating leverage; the key risk is that new-site maturation takes longer or costs more than expected.
• Before underwriting the earnings upgrade, reconcile management’s above-consensus statement with the $585–625 million range versus cited $599 million consensus, and separate reported cash generation from working-capital and supply-chain-financing movements.
• Trim or avoid momentum exposure if room openings weaken, mature managed-center RevPAR rolls over, or year-end cash conversion disappoints; those would undermine the capital-light growth premium.